These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 28579773)
1. Identification of thyroxine-binding globulin as a candidate plasma marker of chronic obstructive pulmonary disease. Diao W; Shen N; Du Y; Sun X; Liu B; Xu M; He B Int J Chron Obstruct Pulmon Dis; 2017; 12():1549-1564. PubMed ID: 28579773 [TBL] [Abstract][Full Text] [Related]
2. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations. Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743 [TBL] [Abstract][Full Text] [Related]
3. Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease. Mandal J; Roth M; Costa L; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D Respiration; 2015; 90(5):357-68. PubMed ID: 26447811 [TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD. Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430 [TBL] [Abstract][Full Text] [Related]
6. MFG-E8, a clearance glycoprotein of apoptotic cells, as a new marker of disease severity in chronic obstructive pulmonary disease. Zhang S; Xie JG; Su BT; Li JL; Hu N; Chen J; Luo GW; Cui TP Braz J Med Biol Res; 2015 Nov; 48(11):1032-8. PubMed ID: 26375445 [TBL] [Abstract][Full Text] [Related]
7. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease. Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of IGFBP7 are elevated during acute exacerbation in COPD patients. Ruan W; Wu M; Shi L; Li F; Dong L; Qiu Y; Wu X; Ying K Int J Chron Obstruct Pulmon Dis; 2017; 12():1775-1780. PubMed ID: 28684903 [TBL] [Abstract][Full Text] [Related]
10. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627 [TBL] [Abstract][Full Text] [Related]
11. Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD. Hu G; Wu Y; Zhou Y; Wu Z; Wei L; Li Y; Peng G; Liang W; Ran P Int J Chron Obstruct Pulmon Dis; 2016; 11():2729-2736. PubMed ID: 27843309 [TBL] [Abstract][Full Text] [Related]
12. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study. Sand JM; Leeming DJ; Byrjalsen I; Bihlet AR; Lange P; Tal-Singer R; Miller BE; Karsdal MA; Vestbo J Respir Res; 2016 Oct; 17(1):125. PubMed ID: 27716343 [TBL] [Abstract][Full Text] [Related]
13. A score to predict short-term risk of COPD exacerbations (SCOPEX). Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896 [TBL] [Abstract][Full Text] [Related]
14. Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Mutlu LC; Altintas N; Aydin M; Tulubas F; Oran M; Kucukyalin V; Kaplan G; Gurel A Inflammation; 2015 Oct; 38(5):1805-13. PubMed ID: 25820390 [TBL] [Abstract][Full Text] [Related]
15. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD. Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105 [TBL] [Abstract][Full Text] [Related]
17. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters. Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD. Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514 [TBL] [Abstract][Full Text] [Related]
19. Proteoglycan 4 is a diagnostic biomarker for COPD. Lee KY; Chuang HC; Chen TT; Liu WT; Su CL; Feng PH; Chiang LL; Bien MY; Ho SC Int J Chron Obstruct Pulmon Dis; 2015; 10():1999-2007. PubMed ID: 26451097 [TBL] [Abstract][Full Text] [Related]
20. Palliative care and prognosis in COPD: a systematic review with a validation cohort. Almagro P; Yun S; Sangil A; Rodríguez-Carballeira M; Marine M; Landete P; Soler-Cataluña JJ; Soriano JB; Miravitlles M Int J Chron Obstruct Pulmon Dis; 2017; 12():1721-1729. PubMed ID: 28652724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]